NZ258044A - Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent - Google Patents

Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent

Info

Publication number
NZ258044A
NZ258044A NZ25804493A NZ25804493A NZ258044A NZ 258044 A NZ258044 A NZ 258044A NZ 25804493 A NZ25804493 A NZ 25804493A NZ 25804493 A NZ25804493 A NZ 25804493A NZ 258044 A NZ258044 A NZ 258044A
Authority
NZ
New Zealand
Prior art keywords
taxol
acid
pharmaceutical composition
organic solvent
solubilising agent
Prior art date
Application number
NZ25804493A
Inventor
David Carver
Robyn Louise Elliott
Hernita Ewald
Gregory Paul Handreck
Timothy Prout
Original Assignee
Faulding F H & Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AUPL607492 priority Critical
Application filed by Faulding F H & Co Ltd filed Critical Faulding F H & Co Ltd
Publication of NZ258044A publication Critical patent/NZ258044A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
NZ25804493A 1992-11-27 1993-11-25 Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent NZ258044A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AUPL607492 1992-11-27

Publications (1)

Publication Number Publication Date
NZ258044A true NZ258044A (en) 1995-12-21

Family

ID=3776561

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ25804493A NZ258044A (en) 1992-11-27 1993-11-25 Pharmaceutical composition comprising taxol, solubilising agent, an acid and an organic solvent

Country Status (8)

Country Link
KR (1) KR100371062B1 (en)
CN (2) CN1096673A (en)
AU (1) AU5553894A (en)
IL (2) IL107776D0 (en)
IN (1) IN176188B (en)
NZ (1) NZ258044A (en)
WO (1) WO1994012198A1 (en)
ZA (1) ZA9308844B (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012031A1 (en) * 1992-11-27 1994-06-09 Napro Biotherapeutics, Inc. Injectable composition
TW406020B (en) * 1993-09-29 2000-09-21 Squibb Bristol Myers Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
FR2710534B1 (en) * 1994-09-28 1996-07-05 Squibb Bristol Myers Co Solvent stabilization pharmaceutical composition thereof, and its method of preparation.
NL9500340A (en) * 1995-02-22 1996-10-01 Yew Tree Pharmaceuticals B V Stabilized paclitaxel solution, and pharmaceutical composition containing the same solution.
US5686488A (en) * 1995-08-25 1997-11-11 Alcon Laboratories, Inc. Polyethoxylated castor oil products as anti-inflammatory agents
AU724842B2 (en) * 1995-12-21 2000-09-28 Genelabs Technologies, Inc. Taxane composition and method
KR100191446B1 (en) * 1996-05-02 1999-06-15 송영욱 Agent cotaining paclitaxel for the treatment of system lupous erythematosus
US6045808A (en) * 1997-01-31 2000-04-04 Pharmacia & Upjohn Company Method for removing high boiling solvents from drug formulations by vacuum drying
DE69716485D1 (en) * 1997-05-30 2002-11-21 Man Woo Han Taxol-containing pharmaceutical solution for injection
BE1011216A3 (en) * 1997-06-13 1999-06-01 Thissen En Abrege L T B Lab Pharmaceutical form for the administration of paclitaxel, method of preparation of a composition paclitaxel ready to employment and use thereof.
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
AU3928202A (en) 2000-11-28 2002-06-11 Transform Pharmaceuticals Inc Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof
DE10115740A1 (en) 2001-03-26 2002-10-02 Ulrich Speck Preparation for the prophylaxis of restenosis
KR100774366B1 (en) * 2001-09-10 2007-11-08 주식회사 중외제약 Injectable composition of paclitaxel
CZ294371B6 (en) * 2002-06-10 2004-12-15 Pliva - Lachema, A. S. Stabilized pharmaceutical composition based on polyoxyethylated castor oil and process for preparing thereof
ES2611054T3 (en) * 2002-06-26 2017-05-04 Syncore Biotechnology Co., Ltd Method for producing a cationic liposomal preparation comprising a lipophilic compound
JP2008543789A (en) * 2005-06-17 2008-12-04 ホスピラ オーストラリア ピーティーワイ エルティーディー Liquid pharmaceutical formulation of docetaxel
EP2399573B1 (en) 2005-08-31 2019-01-02 Abraxis BioScience, LLC Compositions comprising poorly water soluble pharmaceutical agents
CN101396354B (en) * 2007-09-30 2010-12-01 江苏恒瑞医药股份有限公司 Stable taxabe compound liquid combination and preparation method and use thereof
CN101829051B (en) * 2010-05-31 2012-09-12 南昌弘益科技有限公司 1'-acetoxychavicol acetate injection
CN103432109B (en) * 2013-09-01 2015-09-23 吴静 The pharmaceutical composition of paclitaxel

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (en) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Taxol derivatives, their preparation and pharmaceutical compositions containing them
US5157049A (en) * 1988-03-07 1992-10-20 The United States Of America As Represented By The Department Of Health & Human Services Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
US4960790A (en) * 1989-03-09 1990-10-02 University Of Kansas Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
TW223634B (en) * 1991-03-18 1994-05-11 Kingston David G I
WO1992018492A1 (en) * 1991-04-19 1992-10-29 The University Of Mississippi Methods and compositions for isolating taxanes

Also Published As

Publication number Publication date
CN1096673A (en) 1994-12-28
IL107776D0 (en) 1994-02-27
CN1047305C (en) 1999-12-15
WO1994012198A1 (en) 1994-06-09
ZA9308844B (en) 1994-08-02
IL126178D0 (en) 1999-05-09
AU5196793A (en) 1994-06-09
KR100371062B1 (en) 2003-04-21
IN176188B (en) 1996-02-24
AU667142B2 (en) 1996-03-07
CN1095266A (en) 1994-11-23
AU5553894A (en) 1994-06-22

Similar Documents

Publication Publication Date Title
AU685415B2 (en) Taxoids, preparation thereof and pharmaceutical compositions containing same
AU638346C (en) Carbostyril derivatives and pharmaceutical composition containing the same
AU638346B2 (en) Carbostyril derivatives and pharmaceutical composition containing the same
AU3275999A (en) Carboxylic acid derivatives and drugs containing the same as the active ingredient
SK114295A3 (en) Dna construction and pharmaceutical agent containing them
EP0668720A4 (en) M-edta pharmaceutical preparations and uses thereof.
AU4669797A (en) Substituted gamma aminobutyric acids as pharmaceutical agents
IL120531D0 (en) Nitric oxide donors and pharmaceutical compositions containing them
ZA9300649B (en) N-sylfonyl-2-oxoindole derivatives, their preparation and pharmaceutical compositions containing them.
PH31288A (en) Pharmaceutical spheroid formulation.
ZA9206093B (en) Arylethylamine compounds, processes for the preapration thereof and pharmaceutical compositions containing them
EP0427247A3 (en) Pharmaceutical composition with r-alpha-lipoic acid or s-alpha-lipoic acid as the active ingredient
IL110978A (en) 17beta-anilide-4-aza-5alpha-androst-1-en-3-one derivative its preparation and pharmaceutical composition containing it
IE881778L (en) New amino acid derivatives, processes for the preparation¹thereof and pharmaceutical composition comprising the same
SK83698A3 (en) Insulin derivatives with rapid onset of action, preparation method thereof and pharmaceutical composition containing the same
HU9602188D0 (en) Novel carbamate derivative and medicinal composition containing the same
PL304498A1 (en) Novel tricyclic diasepines, their transient compounds, pharmaceutical agents and methods of obtaining such compounds
IL135920D0 (en) 2-aryl -8-oxodihydropurine derivative, process for the preparation thereof, pharmaceutical composition containing the same and intermediate therefor
AU6307290A (en) Pyrazole derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
IL133891D0 (en) 2-valproenoic acid amide derivatives, their preparation and pharmaceutical compositions containing them
NZ238586A (en) Pyrazolopyrimidinone derivatives; intermediates, preparatory processes, pharmaceutical compositions, and use thereof
OA9458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
IL95590D0 (en) Pharmaceutical compositions comprising salmeterol and fluticasone propionate
AU1176995A (en) Taxol formulation
NZ254864A (en) N-(carboxyalkyl)-n'-(4-aminophenyl)urea derivatives, the corresponding 4-aminophenylacetamide and -carbamic acid ester analogues and pharmaceutical compositions thereof

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: MAYNE PHARMA PTY LIMITED, AU

Free format text: OLD OWNER(S): MAYNE PHARMA PTY LIMITED; F H FAULDING AND CO LIMITED

RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
EXPY Patent expired